Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02239250
Other study ID # NCT01882777_2
Secondary ID
Status Completed
Phase N/A
First received September 9, 2014
Last updated September 9, 2016
Start date August 2014
Est. completion date March 2016

Study information

Verified date February 2015
Source London School of Hygiene and Tropical Medicine
Contact n/a
Is FDA regulated No
Health authority United Kingdom: LSHTM Research Ethics CommitteeRwanda: National Ethics Committee, Ministry of Health
Study type Interventional

Clinical Trial Summary

DelAgua Health Rwanda (Implementation) Ltd. together with Rwanda Ministry of Health (MoH) are delivering an intervention, consisting on the free distribution of one advance water filter and one improved cookstove to all household classified as ubudehe 1 and 2 according to government approved registers (poorest tertile), in Western Province. The aim of this intervention is to reduce the morbidity and mortality associated with diarrhoeal diseases and pneumonia in Rwanda.

The London School of Hygiene and Tropical Medicine (LSHTM) will be undertaking an independent evaluation of this large-scale intervention to assess its impact on health. The trial will evaluate whether the provision of improved cookstoves and advance water filters can reduce pneumonia and diarrhoea disease in children under 5 years of age.

A cluster randomized controlled trial (CRCT) with two arms of unequal size (3:1 ratio) will be use to answer this question. The 96 sectors in Western Province, Rwanda, will be randomised to either receive the intervention or the control. Each eligible household in intervention sectors will receive one EcoZoom™ Spartan and one Vestergaard Frandsen Lifestraw Family™ 2.1 water filter free of charge. Eligible households in control sectors will continue with their traditional cooking and drinking practices. Health data on children under 5 years of age will be collected from community health worker (CHW) and health facility records all across Western Province to evaluate the health impact of the intervention. The study will encompass 12 months of follow-up. After this time the control sectors will receive the intervention.

This independent evaluation will also include a nested village-level study within the larger sector-level study, with the aim to evaluate uptake, consistent use and acceptability of the intervention, as well as to assess the impact on environmental exposures and health outcomes. 174 villages (74 controls and 74 intervention) will be selected for participation. Household surveys will be used to collect data on intervention use and acceptability as well as on self-reported health data. Water samples will be collected and monitoring of exposure to Households Air Pollution (HAP) will be undertaken. Measurements of blood pressure, expirated Carbon monoxide (CO) and pulse CO-oximetry will be undertake in primary cooks and or children under 5 years of age. Additionally, as part of this nested study, two exploratory studies will also be conducted. One will be focused on assessing the potential of biomarkers as indicators of environmental exposures (mainly HAP and water quality) and health status, while the other exploratory sub-study will assess the reactivity of participants to the use of remotely reporting electronic sensors to measure target behaviours.


Recruitment information / eligibility

Status Completed
Enrollment 1582
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Both
Age group N/A to 5 Years
Eligibility Inclusion Criteria:

- For Sector-level study:

- All households shown on updated 2012 government registers to be members of ubudehe 1 and 2 in Western Province, Rwanda will be eligible to participate in the study.

- For nested village-level study:

- All villages from all sectors in Western province, according to official Government lists will be eligible for participation with the exception of those villages that were selected for participation in Phase 1.

- At the village-level, all households that are classified as ubudehe 1 & 2 according to updated 2012 government registers, are part of the village, are able to provide informed consent, and that have at least one child under 4 years of age at the time of enrollment will be eligible for participation. Presence of a child under 4 years of age will be assessed by checking dates of birth or recorded age in months in the CHW register of children <5 years (Igitabo Cy'Ibikorwa Byo Gukurikirana), which are maintained at the village by CHW (though occasionally these are transferred to health centers). If this data is missing will be assesses based on CHW's report. In those cases where a village has more than the required number of participating households (10 household), a random selection of 10 households will be drawn.

- For the assessment of personal exposure to HAP a stricter set of eligibility criteria will be applied. Households that comply with the following eligibility criteria will be eligible for the exposure to HAP sub-study.

- Have a child 1.5-4 year old,

- Have a child healthy enough to wear the monitoring equipment (as perceived by the mother),

- Have a non-smoking primary cook,

- Have a primary cook that is currently not pregnant (as far as she is aware of), and

- Have a primary cook that is in a healthy state to wear the monitoring equipment

- The first two households identified from a randomised list will be invited to participate.

- For the biomarker sub-studies, both the primary cook and the child under 4 years of age from households undergoing HAP exposure assessment will be eligible for the inflammatory cytokine biomarker study. For the enteric seroconversion study, all children aged 6 to 12 months will be eligible for participation.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Intervention

Device:
Water filter and cookstove
The Vestergaard Frandsen Lifestraw Family™ 2.1 is a point-of-use water treatment system.Water is poured through a 20 micron pre-filter into a 6L influent water tank.This water then filters through a 0.20 micron hollow-fiber ultrafiltration membrane into a 5.5L storage container.Water is then poured through a plastic tap, which prevents re-contamination.This system filters up to 18,000L of water.The system exceeds the WHO's "highly protective" standard for household water treatment technologies.The EcoZoom™ Spartan stove concentrates the combustion process while channeling airflow to completely burn the fuel provided.The stove has a ceramic combustion chamber within a steel housing, which is topped with a cast iron stove.The stove includes a rack for placing firewood and a pot skirt that improves the thermal efficiency.The cookstoves and filters will be delivered together at no cost to participating households.Households will receive instructions on how to operate these devices.

Locations

Country Name City State
Rwanda Manna Energy Ltd. Kigali

Sponsors (8)

Lead Sponsor Collaborator
London School of Hygiene and Tropical Medicine DelAgua, Emory University, Ministry of Health, Rwanda, National University, Rwanda, Oregon Health and Science University, Portland State University, University of Colorado, Boulder

Country where clinical trial is conducted

Rwanda, 

Outcome

Type Measure Description Time frame Safety issue
Other Prevalence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Prevalence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 &2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Prevalence of self-reported diarrhoea among primary cooks This outcome measure will be assessed in the nested village-level study. 12 months No
Other Prevalence of self-reported respiratory conditions among primary cooks in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Mena difference in blood pressure in primary cooks in ubudehe 1 and 2 categories Mean difference of systolic and diastolic measured separately. This outcome measure will be assessed in the nested village-level study. 12 months No
Other Mean difference in levels of expirated CO in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Mean difference levels of Carboxyhaemoglobin in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Percentage seroconversion against enteric pathogens in children 6-12 months of age at enrolment in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Mean difference in inflammatory cytokines in children under 5 years of age in unudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Median difference in 48-h personal exposure to PM2.5 in children under 5 years of age and primary cooks in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Other Levels of faecal contamination in drinking water This outcome measure will be assessed in the nested village-level study. Proportion of water samples samples free of faecal contamination. 12 months No
Other Levels of consistent use of the intervention This outcome measure will be assessed in the intervention group only of the nested village-level study.
Percentage of households reporting the use of the stove as their primary stove in all follow-up visits. Percentage of households reporting their current drinking water was treated by the intervention filter in all follow-up visits.
12 months No
Primary Incidence of IMCI defined pneumonia in children under 5 years of age in ubudehe 1 & 2 categories All types of pneumonia (severe, non severe). This outcome measure will be assessed in the sector-level study. 12 months No
Primary Incidence of IMCI defined diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories All types of diarrhoea (including severe, persistent, dysentery). This outcome measure will be assessed in the sector-level study. 12 months No
Secondary All-cause mortality in children under 5 years of age in ubudehe 1 & categories This outcome measure will be assessed in the sector-level study. 12 months No
Secondary Incidence of maternal health outcomes among women un ubudehe 1 & 2 categories Incidence of maternal health outcomes including low birth weight, premature birth, and still birth 12 months No
Secondary Prevalence of self-reported diarrhoea in children under 5 years of age in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
Secondary Prevalence of pneumonia in children under 5 years of age in ubudehe 1 & 2 categories This outcome measure will be assessed in the nested village-level study. 12 months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Completed NCT05815264 - Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above Phase 1
Recruiting NCT04589936 - Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care N/A
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Completed NCT06210737 - A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years Phase 4
Terminated NCT03944551 - Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa N/A
Terminated NCT04660084 - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT05702788 - Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) Phase 2
Not yet recruiting NCT04171674 - Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation. N/A
Active, not recruiting NCT03140163 - Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR] N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Recruiting NCT02515565 - Physiotherapy in Patients Hospitalized Due to Pneumonia. N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01399723 - Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia Phase 3
Completed NCT01416506 - Community-Acquired Pneumonia (CAP) Surveillance N/A
Terminated NCT02358642 - Drug to Prevent Pneumonia in the Tube Fed Phase 4